Salt handling and hypertension

Journal of Clinical Investigation

Volumn 113, Issue 8, 2004, Pages 1075-1081

  O'Shaughnessy, Kevin M ^a   Karet, Fiona E ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHLORIDE;

BLOOD PRESSURE MEASUREMENT; HUMAN; HYPERTENSION; KIDNEY FUNCTION; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SALT INTAKE; SODIUM BALANCE; SODIUM RESTRICTION;

ALKALOSIS; ANIMALS; BARTTER SYNDROME; HUMANS; HYPERTENSION; KIDNEY; PSEUDOHYPOALDOSTERONISM; SODIUM; SODIUM, DIETARY;

EID: 2142767411     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200421560     Document Type: Review

References (74)

1. Taubes, G. 1998. The (political) science of salt. Science. 281:898-907.
2. Taubes, G. 2000. A DASH of data in the salt debate. Science. 288:1319.
3. Veith, I. 1949. Huang Ti Nei Ching Su Wen. The Yellow Emperor's Classic of Internal Medicine. Williams & Wilkins. Baltimore, Maryland, USA. 253 pp.
4. Dahl, L.K., and Heine, M. 1975. Primary role of renal homografts in setting chronic blood pressure levels in rats. Circ. Res. 36:692-696.
5. Guyton, A.C. 1991. Abnormal renal function and autoregulation in essential hypertension. Hypertension. 18:49-53.
6. Guyton, A.C. 1991. Blood pressure control: special role of the kidneys and body fluids. Science. 252:1813-1816.
7. Lifton, R.P., Gharavi, A.G., and Geller, D.S. 2001. Molecular mechanisms of human hypertension. Cell. 104:545-556.
8. Liddle, G., Bledsoe, T., and Coppage, W. 1963. A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans. Assoc. Am. Physicians. 76:199-213.
9. Botero-Velez, M., Curtis, J.J., and Warnock, D.G. 1994. Brief report Liddle's syndrome revisited: a disorder of sodium reabsorption in the distal tubule. N. Engl. J. Med. 330:178-181.
10. Shimkets, R.A., et al. 1994. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell. 79:407-414.
11. Hansson, J.H., et al. 1995. Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat. Genet. 11:76-82.
12. + channel is made of three homologous subunits. Nature. 367:463-467.
13. + channel deleted in Liddle's syndrome. EMBO J. 15:2371-2380.
14. Snyder, P.M., Steines, J.C., and Olson, D.R. 2004. Relative contribution of Nedd4 and Nedd4-2 to ENaC regulation in epithelia determined by RNA interference. J. Biol. Chem. 279:5042-5046.
15. + channels. J. Biol. Chem. 274:16973-16978.
16. Chen, S.Y., et al. 1999. Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc. Natl. Acad. Sci. U. S. A. 96:2514-2519.
17. Cheek, D.B., and Perry, J.W. 1958. A salt wasting syndrome in infancy. Arch. Dis. Child. 33:252-256.
18. Chang, S.S., et al. 1996. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat. Genet. 12:248-253.
19. Strautnieks, S.S., Thompson, R.J., Gardiner, R.M., and Chung, E. 1996. A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families. Nat. Genet. 13:248-250.
20. Kerem, E., et al. 1999. Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism. N. Engl. J. Med. 341:156-162.
21. Bartter, F.C., Pronove, P., Gill, J.R., Jr., and MacCardle, R.C. 1962. Hyperplasia of the juxtaglomerular complex with hyperaldostetonism and hypokalemic alkalosis. A new syndrome. Am. J. Med. 33:811-828.
22. Gitelman, H.J., Graham, J.B., and Welt, L.G. 1966. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans. Assoc. Am. Physicians. 79:221-235.
23. Bettinelli, A., et al. 1992. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J. Pediatr. 120:38-43.
24. Simon, D.B., et al. 1996. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat. Genet. 13:183-188.
25. + channel, ROMK. Nat. Genet. 14:152-156.
26. Simon, D.B., et al. 1997. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat. Genet. 17:171-178.
27. = secretion. Nature. 414:558-561.
28. Birkenhager, R., et al. 2001. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat. Genet. 29:310-314.
29. Cruz, D.N., Shaer, A.J., Bia, M.J., Lifton, R.P., and Simon, D.B. 2001. Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int. 59:710-717.
30. Simon, D.B., et al. 1996. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat. Genet. 12:24-30.
31. Gordon, R.D., Geddes, R.A., Pawsey, C.G., and O'Halloran, M.W. 1970. Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction. Australas. Ann. Med. 19:287-294.
32. Mansfield, T.A., et al. 1997. Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21. Nat Genet. 16:202-205.
33. Disse-Nicodeme, S., et al. 2000. A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension. Am. J. Hum. Genet. 67:302-310.
34. Wilson, F.H., et al. 2001. Human hypertension caused by mutations in WNK kinases. Science. 293:1107-1112.
35. Choate, K.A., Kahle, K.T., Wilson, F.H., Nelson-Williams, C., and Lifton, R.P. 2003. WNK1, a kinase mutated in inherited hypertension with hyperkalemia, localizes to diverse CI-transporting epithelia. Proc. Natl. Acad. Sci. U. S. A. 100:663-668.
36. Yang, C.-L., Angell, J., Mitchell, R., and Ellison, D.H. 2003. WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J. Clin. Invest. 111:1039-1045. doi:10.1172/JCI200317443.
37. Wilson, F.H., et al. 2003. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc. Natl. Acad. Sci. U. S. A. 100:680-684.
38. + secretion. Nat. Genet. 35:372-376.
39. Jeunemaitre, X. 2003. Renin-angiotensin-aldosterone system polymorphisms and essential hypertension: where are we? J. Hypertens. 21:2219-2222.
40. Harrap, S.B. 2003. Where are all the blood-pressure genes? Lancet. 361:2149-2151.
41. Corvol, P., Persu, A., Gimenez-Roqueplo, A.P., and Jeunemaitre, X. 1999. Seven lessons from two candidate genes in human essential hypertension: angiotensinogen and epithelial sodium channel. Hypertension. 33:1324-1331.
42. Province, M.A., et al. 2003. A meta-analysis of genome-wide linkage scans for hypertension: the National Heart, Lung and Blood Institute Family Blood Pressure Program. Am. J. Hypertens. 16:144-147.
43. Kim, H.S., et al. 1995. Genetic control of blood pressure and the angiotensinogen locus. Proc. Natl. Acad. Sci. U. S. A. 92:2735-2739.
44. Kim, H.S., et al. 1999. Homeostasis in mice with genetically decreased angiotensinogen is primarily by an increased number of renin-producing cells. J. Biol. Chem. 274:14210-14217.
45. Pradervand, S., et al. 2003. Dysfunction of the epithelial sodium channel expressed in the kidney of a mouse model for Liddle syndrome. J. Am. Soc. Nephrol. 14:2219-2228.
46. + channels is maintained in a mouse model of Liddle's syndrome. Am. J. Physiol. Renal Physiol. 285:F310-F318.
47. Dahl, L.K., Heine, M., and Tassinari, L. 1962. Effects of chronic excess salt ingestion: evidence that genetic factors play an important role in susceptibility to experimental hypertension. J. Exp. Med. 115:1173-1190.
48. Denton, D., et al. 1995. The effect of increased salt intake on blood pressure of chimpanzees. Nat. Med. 1:1009-1016.
49. Dahl, L.K. 1960. Possible role of salt intake in the development of essential hypertension. In Essential hypertension: an international symposium. P. Cottier and K.D. Bock, editors. Springer-Verlag. Berlin, Germany. 61-75.
50. 1988. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. Br. Med. J. 297:319-328.
51. Elliott, P., et al. 1996. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. Br. Med. J. 312:1249-1253.
52. Law, M.R., Frost, C.D., and Wald, N.J. 1991. By how much does dietary salt reduction lower blood pressure? III. Analysis of data from trials of salt reduction. Br. Med. J. 302:819-824.
53. He, F.J., and MacGregor, G.A. 2003. How far should salt intake be reduced? Hypertension. 42:1093-1099.
54. Sacks, F.M., et al. 2001. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N. Engl. J. Med. 344:3-10.
55. Neri, L.C., and Johansen, H.L. 1978. Water hardness and cardiovascular mortality. Ann. N.Y. Acad. Sci. 304:203-221.
56. Lind, L., Lithell, H., Gustafsson, I.B., Pollare, T., and Ljunghall, S. 1993. Calcium metabolism and sodium sensitivity in hypertensive subjects. J. Hum. Hypertens. 7:53-57.
57. Cappuccio, F.P., and MacGregor, G.A. 1991. Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J. Hypertens. 9:465-473.
58. Ascherio, A., et al. 1998. Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation. 98:1198-1204.
59. Verhaar, M.C., Stroes, E., and Rabelink, T.J. 2002. Folates and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 22:6-13.
60. Rathaus, M., and Bernheim, J. 2002. Oxygen species in the microvascular environment: regulation of vascular tone and the development of hypertension. Nephrol. Dial. Transplant. 17:216-221.
61. 2004. Dietary reference intakes: water, potassium, sodium, chloride, and sulfate. Report of the Institute of Medicine of the National Academies. Washington, DC, USA. http://www.iom.edu/report.asp?id=18495.
62. Luft, F.C., and Weinberger, M.H. 1997. Heterogeneous responses to changes in dietary salt intake: the salt-sensitivity paradigm. Am. J. Clin. Nutr. 65(Suppl. 2):612S-617S.
63. Luft, F.C., et al. 1987. Influence of genetic variance on sodium sensitivity of blood pressure. Klin. Wochenschr. 65:101-109.
64. Svetkey, L.P., et al. 2001. Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study. J. Hypertens. 19:1949-1956.
65. Weir, M.R., et al. 1998. Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives. Hypertension. 31:1088-1096.
66. Berghoff, R.S., and Geraci, A.S. 1929. The influence of sodium chloride on blood pressure. Br. Med. J. 56:395-397.
67. Shore, A.C., Markandu, N.D., and MacGregor, G.A. 1988. A randomized crossover study to compare the blood pressure response to sodium loading with and without chloride in patients with essential hypertension. J. Hypertens 6:613-617.
68. Kurtz, T.W., Al Bander, H.A., and Morris, R.C., Jr. 1987. "Salt-sensitive" essential hypertension in men. Is the sodium ion alone important? N. Engl. J. Med. 317:1043-1048.
69. Dodic, M., Moritz, K., Koukoulas, I., and Wintour, E.M. 2002. Programmed hypertension: kidney, brain or both? Trends Endocrinol. Metab. 13:403-408.
70. Zicha, J., and Kunes, J. 1999. Ontogenetic aspects of hypertension development: analysis in the rat. Physiol. Rev. 79:1227-1282.
71. Holliday, M.A. 1995. Is blood pressure in later life affected by events in infancy? Pediatr. Nephrol. 9:663-666.
72. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. 2003. Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension. 42:239-246.
73. Luft, F.C., Morris, C.D., and Weinberger, M.H. 1997. Compliance to a low-salt diet. Am. J. Clin. Nutr. 65(Suppl. 2):698S-703S.
74. Collins, R., et al. 1990. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 335:827-838.